TaiTsun (4169) Corrects Misstatements in Q1 2026 Consolidated Financial Report

Date of issue: 2026/05/21 Date of statement: 2026/05/20 Time of statement: 17:11:47 Company code: 4169 Company name: TaiTsun Subject: Correction of misstatements in the Company's Q1 2026 consolidated financial report Applicable clause: Article 51 Date of occurrence: 2026/05/20 Description: 1. Date of occurrence: 2026/05/20 2. Company name: TaiTsun Biopharmaceutical Co., Ltd. 3. Relationship to the Company: The Company 4. Mutual shareholding ratio: Not applicable 5. Reason for occurrence: In the Q1 2026 cash flow statement, the signs for 'Interest expense' and 'Interest paid' were incorrect, and 'Interest income' and 'Interest received' were omitted. 6. Corrected information item/report name: The Company's Q1 2026 consolidated financial report, Q1 2026 iXBRL filing information 7. Amount/content/page before correction: Cash Flow Statement Page 10 From Jan 1, 2026 to Mar 31, 2026 / From Jan 1, 2025 to Mar 31, 2025 ---------------------------------------------------- Interest expense (166) / (226) Interest paid 166 / 226 8. Amount/content/page after correction: Cash Flow Statement Page 10 From Jan 1, 2026 to Mar 31, 2026 / From Jan 1, 2025 to Mar 31, 2025 ---------------------------------------------------- Interest expense 166 / 226 Interest...